-
Posted: January 13th, 2023, 3:00pm GMT
Conditions: Soft Tissue Sarcoma; Adult Soft Tissue Sarcoma; Resectable Soft Tissue Sarcoma
Interventions: Radiation: Neoadjuvant RT; Other: Pre-radiotherapy mpMRI; Other: Post-radiotherapy mpMRI; Procedure: Tumor resection
Sponsor: Centre Leon Berard
Not yet recruiting
-
Posted: January 13th, 2023, 3:00pm GMT
Conditions: Localized Osteosarcoma; Metastatic Osteosarcoma; Resectable Osteosarcoma; Unresectable Osteosarcoma
Interventions: Drug: Cabozantinib S-malate; Drug: Methotrexate; Drug: Doxorubicin Hydrochloride; Drug: Cisplatin; Procedure: X-Ray Imaging; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Bone Scan
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: January 11th, 2023, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Drug: pembrolizumab, pazopanib
Sponsor: Yonsei University
Not yet recruiting
-
Posted: January 10th, 2023, 3:00pm GMT
Conditions: Neurofibromatosis 1; Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis); Atypical Neurofibroma
Intervention: Diagnostic Test: Whole Body Magnetic Resonance Imaging
Sponsor: Johns Hopkins University
Recruiting
-
Posted: December 23rd, 2022, 3:00pm GMT
Conditions: Anal Carcinoma; Hematopoietic and Lymphoid Cell Neoplasm; HIV Infection; Kaposi Sarcoma; Lymphoma; Malignant Solid Neoplasm; Multicentric Castleman Disease; Plasmablastic Lymphoma; Recurrent Kaposi Sarcoma; Recurrent Lymphoma; Recurrent Plasmablastic Lymphoma; Transplant-Related Kaposi Sarcoma
Intervention: Procedure: Biospecimen Collection
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: December 21st, 2022, 3:00pm GMT
Condition: Pulmonary Osteosarcoma
Intervention: Biological: RNA-LP vaccine
Sponsors: University of Florida; The V Foundation for Cancer Research
Not yet recruiting
-
Posted: December 19th, 2022, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Device: Cadonilimab
Sponsor: Peking University Cancer Hospital & Institute
Not yet recruiting
-
Posted: December 19th, 2022, 3:00pm GMT
Conditions: Advanced Breast Cancer; Treatment-Refractory Solid Tumors; Retinoblastoma Deficiency; SCLC; Soft Tissue Sarcoma; Endometrial Cancer; Bladder Cancer
Interventions: Drug: Palbociclib Oral Product; Drug: TAS-116
Sponsors: Brown University; Taiho Oncology, Inc.
Not yet recruiting
-
Posted: December 16th, 2022, 3:00pm GMT
Condition: Leiomyosarcoma
Intervention: Other: Plasma Collection
Sponsors: University of Michigan Rogel Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: December 7th, 2022, 3:00pm GMT
Condition: Hepatic Sarcoma
Intervention:
Sponsor: University Hospital, Strasbourg, France
Recruiting
-
Posted: November 17th, 2022, 3:00pm GMT
Condition: Advanced Soft-tissue Sarcoma
Intervention: Biological: NY-ESO-1 TCR-T
Sponsor: Shenzhen University General Hospital
Recruiting
-
Posted: October 27th, 2022, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Other: Supervised Exercise by a physiotherapist via face to face
Sponsor: Istanbul Medeniyet University
Not yet recruiting
-
Posted: September 22nd, 2022, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Biological: NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)
Sponsors: Sun Yat-sen University; Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Recruiting
-
Posted: August 25th, 2022, 2:00pm GMT
Conditions: Sarcoma,Soft Tissue; Sarcoma Uterus
Intervention: Drug: Niraparib
Sponsors: Memorial Sloan Kettering Cancer Center; GlaxoSmithKline
Recruiting
-
Posted: August 11th, 2022, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Drug: Chiauranib
Sponsor: Chipscreen Biosciences, Ltd.
Recruiting
-
Posted: July 12th, 2022, 2:00pm GMT
Condition: Sarcoma
Intervention: Other: No intervention
Sponsor: Henan Cancer Hospital
Recruiting
-
Posted: June 15th, 2022, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Ga-68-PSMA-11 PET/CT; Drug: Lu-177-ITG-PSMA-1
Sponsor: John O. Prior
Not yet recruiting
-
Posted: May 13th, 2022, 2:00pm GMT
Condition: Sarcoma
Intervention: Other: Surgery
Sponsors: Radboud University Medical Center; Radiotherapiegroep
Recruiting
-
Posted: May 3rd, 2022, 2:00pm GMT
Condition: Undifferentiated Round Cell Sarcoma
Intervention: Other: data collection and analysis on Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissue
Sponsor: Istituto Ortopedico Rizzoli
Recruiting
-
Posted: May 2nd, 2022, 2:00pm GMT
Conditions: Synovial Sarcoma; Soft Tissue Sarcoma
Intervention: Drug: CFT8634
Sponsor: C4 Therapeutics, Inc.
Recruiting
-
Posted: March 29th, 2022, 2:00pm GMT
Condition: High Grade Sarcoma
Interventions: Radiation: Intensity Modulated Radiation Therapy (IMRT); Diagnostic Test: MRI
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Viewray Inc.
Recruiting
-
Posted: March 11th, 2022, 3:00pm GMT
Conditions: Ewing Sarcoma; Ewing-Like Sarcoma
Interventions: Drug: LY2880070; Drug: Gemcitabine
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting
-
Posted: March 9th, 2022, 3:00pm GMT
Condition: Sarcoma
Intervention: Other: NETSARC network
Sponsors: Centre Leon Berard; École nationale supérieure des Mines Saint-Etienne France; Rennes University Hospital; Assistance Publique - Hôpitaux de Paris
Recruiting
-
Posted: March 2nd, 2022, 3:00pm GMT
Condition: Advanced High-grade Sarcoma
Intervention: Drug: TQB2858 injection
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Not yet recruiting
-
Posted: January 27th, 2022, 3:00pm GMT
Condition: Relapsed Sarcomas
Interventions: Drug: Disulfiram; Drug: Copper Gluconate; Drug: Liposomal Doxorubicin (Doxil)
Sponsor: Case Comprehensive Cancer Center
Recruiting
-
Posted: January 14th, 2022, 3:00pm GMT
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Recombinant anti-PD-1 humanized monoclonal antibody injection
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Not yet recruiting
-
Posted: January 12th, 2022, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Albumin-Bound Paclitaxel; Drug: Camrelizumab
Sponsor: Henan Cancer Hospital
Recruiting
-
Posted: December 28th, 2021, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Other: Prediction model
Sponsor: West China Hospital
Recruiting
-
Posted: December 2nd, 2021, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Drug: Fruquintinib
Sponsor: Fudan University
Recruiting
-
Posted: November 30th, 2021, 3:00pm GMT
Condition: Sarcoma, Soft Tissue
Interventions: Drug: 609A; Drug: doxorubicin hydrochloride
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Not yet recruiting
-
Posted: November 16th, 2021, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Anlotinib hydrochloride capsule; Drug: Epirubicin; Drug: Arotinib hydrochloride capsule placebo
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
-
Posted: November 10th, 2021, 3:00pm GMT
Condition: Soft Tissue Sarcoma Adult
Interventions: Combination Product: AZD1390 + radiotherapy; Combination Product: AZD7648 + radiotherapy
Sponsors: The Netherlands Cancer Institute; Leiden University Medical Center; University Medical Center Nijmegen
Recruiting
-
Posted: November 5th, 2021, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Radiation: Conventional Fractionated; Radiation: Hypofractionated
Sponsor: University of Wisconsin, Madison
Recruiting
-
Posted: November 4th, 2021, 2:00pm GMT
Condition: Sarcoma
Intervention: Drug: Surufatinib
Sponsor: Sun Yat-sen University
Recruiting
-
Posted: October 29th, 2021, 2:00pm GMT
Condition: Metastatic Soft-tissue Sarcoma
Interventions: Drug: NOX66; Drug: Doxorubicin
Sponsor: Noxopharm Limited
Recruiting
-
Posted: September 27th, 2021, 2:00pm GMT
Conditions: Sarcoma; Soft Tissue Sarcoma
Interventions: Radiation: Interstitial radiation therapy; Radiation: Postoperative external beam therapy
Sponsor: Blokhin's Russian Cancer Research Center
Recruiting
-
Posted: September 23rd, 2021, 2:00pm GMT
Condition: Pelvic Sarcoma
Interventions: Other: Functional Assessment; Procedure: X-Ray Imaging
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: September 16th, 2021, 2:00pm GMT
Condition: Sarcoma, Ewing
Intervention: Biological: TK216+Vincristin
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Not yet recruiting
-
Posted: July 20th, 2021, 2:00pm GMT
Condition: Resectable Sarcoma
Interventions: Drug: Doxorubicin; Drug: Ifosfamide; Drug: INCMGA00012
Sponsors: Institut Bergonié; Incyte Biosciences International Sàrl
Recruiting
-
Posted: July 16th, 2021, 2:00pm GMT
Condition: Advanced Synovial Sarcoma
Intervention: Drug: FHD-609
Sponsor: Foghorn Therapeutics Inc.
Recruiting
-
Posted: June 30th, 2021, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Radiation: Protons; Radiation: carbon ions
Sponsor: University Hospital Heidelberg
Recruiting
-
Posted: June 28th, 2021, 2:00pm GMT
Condition: Kaposi Sarcoma
Intervention: Drug: Abemaciclib
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: June 10th, 2021, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Other: neoadjuvant exercise therapy
Sponsors: Duke University; University of North Carolina, Chapel Hill
Recruiting
-
Posted: May 5th, 2021, 2:00pm GMT
Conditions: Advanced Soft-tissue Sarcoma; Metastatic Soft-tissue Sarcoma
Interventions: Drug: Bintrafusp alfa; Drug: Doxorubicin
Sponsors: Institut Bergonié; Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Recruiting
-
Posted: April 15th, 2021, 2:00pm GMT
Condition: Ewing Sarcoma of Bone
Intervention: Other: Treatment of Ewings Sarcoma of bone according clinical practice (includes drugs, surgery, radiotherapy or any other received treatments)
Sponsor: Italian Sarcoma Group
Recruiting
-
Posted: March 17th, 2021, 2:00pm GMT
Condition: Sarcoma
Intervention: Drug: Autologous CIK
Sponsor: Prof. Franca Fagioli
Recruiting
-
Posted: March 5th, 2021, 3:00pm GMT
Condition: Advanced Sarcoma
Interventions: Drug: Lenvatinib; Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center; Merck Sharp & Dohme LLC; Parker Institute for Cancer Immunotherapy
Recruiting
-
Posted: March 1st, 2021, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Ifosfamide; Drug: Doxorubicin
Sponsors: Oslo University Hospital; Haukeland University Hospital
Recruiting
-
Posted: February 11th, 2021, 3:00pm GMT
Condition: Breast Sarcoma
Intervention: Other: Treatment of Breast Sarcoma according clinical practice (includes drugs, surgery or any other received treatments)
Sponsor: Italian Sarcoma Group
Recruiting
-
Posted: February 5th, 2021, 3:00pm GMT
Condition: Sarcoma
Interventions: Drug: Nivolumab and IPILIMUMAB; Drug: Pazopanib Oral Tablet [Votrient]
Sponsor: Centre Leon Berard
Recruiting
-
Posted: December 7th, 2020, 3:00pm GMT
Condition: Soft Tissue Sarcoma Adult
Interventions: Drug: Cyclophosphamide; Drug: Doxorubicin
Sponsors: Istituto Oncologico Veneto IRCCS; Ministry of Health, Italy
Recruiting
-
Posted: November 5th, 2020, 3:00pm GMT
Condition: Soft Tissue Sarcoma Adult
Intervention: Radiation: Hypofractionation
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Recruiting
-
Posted: October 28th, 2020, 2:00pm GMT
Condition: Sarcoma,Soft Tissue
Intervention: Drug: pemetrexed+cisplatin
Sponsor: Yonsei University
Recruiting
-
Posted: October 28th, 2020, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Drug: Camrelizumab in Combination With Neoadjuvant Chemotherapy
Sponsors: Sun Yat-sen University; Jiangsu HengRui Medicine Co., Ltd.
Recruiting
-
Posted: October 22nd, 2020, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Talimogene Laherparepvec; Radiation: Radiotherapy
Sponsors: Varun Monga, MD; Amgen
Recruiting
-
Posted: October 8th, 2020, 2:00pm GMT
Condition: Skin Kaposi Sarcoma
Intervention: Drug: Pomalidomide
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: September 2nd, 2020, 2:00pm GMT
Condition: Sarcoma
Interventions: Drug: Gemcitabine; Drug: Doxorubicin; Drug: Docetaxel; Drug: Nivolumab
Sponsor: Sarcoma Oncology Research Center, LLC
Recruiting
-
Posted: August 17th, 2020, 2:00pm GMT
Condition: Sarcoma
Intervention: Other: Surgical prehabilitation program.
Sponsor: Institut Claudius Regaud
Recruiting
-
Posted: August 10th, 2020, 2:00pm GMT
Condition: Soft Tissue Sarcomas
Intervention: Radiation: Hypofractionated Radiotherapy
Sponsor: Vanderbilt-Ingram Cancer Center
Recruiting
-
Posted: July 8th, 2020, 2:00pm GMT
Condition: Sarcoma
Intervention: Procedure: Enhanced Recovery After Surgery
Sponsor: Joshua Lawrenz
Recruiting
-
Posted: June 11th, 2020, 2:00pm GMT
Condition: Soft Tissue Sarcomas
Intervention: Radiation: pre-operative radiotherapy
Sponsors: The Netherlands Cancer Institute; Leiden University Medical Center
Recruiting
-
Posted: April 22nd, 2020, 2:00pm GMT
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Sintilimab; Drug: Doxorubicin Hydrochloride; Drug: Ifosfamide
Sponsors: Fudan University; Zhejiang Cancer Hospital; Tongji Hospital; Xijing Hospital; Shanghai Zhongshan Hospital
Recruiting
-
Posted: March 13th, 2020, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Standard of care + chemotherapy; Other: Standard of care
Sponsor: Institut Claudius Regaud
Recruiting
-
Posted: March 10th, 2020, 2:00pm GMT
Condition: Kaposi Sarcoma
Interventions: Drug: NHS-IL12; Drug: M7824
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: March 9th, 2020, 2:00pm GMT
Condition: Sarcoma
Intervention:
Sponsors: Kantonsspital Winterthur KSW; SwissSarcomaNetwork
Recruiting
-
Posted: February 28th, 2020, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Radiation: Intensity-modulated radiation therapy (IMRT)
Sponsors: Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH)
Recruiting
-
Posted: February 18th, 2020, 3:00pm GMT
Condition: Sarcoma, Clear Cell
Intervention: Drug: TSR-042
Sponsors: Italian Sarcoma Group; GlaxoSmithKline
Recruiting
-
Posted: January 13th, 2020, 3:00pm GMT
Condition: Retroperitoneal Sarcoma
Intervention: Device: PET MRI scan
Sponsor: University Health Network, Toronto
Recruiting
-
Posted: January 6th, 2020, 3:00pm GMT
Condition: Sarcoma,Soft Tissue
Interventions: Radiation: Proton radiation; Radiation: Carbon Ion radiation
Sponsor: University Hospital Heidelberg
Recruiting
-
Posted: December 6th, 2019, 3:00pm GMT
Condition: Retroperitoneal Sarcoma
Interventions: Drug: Liposomal Bupivacaine; Drug: Quadratus Lumborum Block; Other: Questionnaire Administration
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: November 21st, 2019, 3:00pm GMT
Condition: Sarcoma,Soft Tissue
Intervention: Drug: anlotinib and toripalimab
Sponsor: Sun Yat-sen University
Recruiting
-
Posted: October 11th, 2019, 2:00pm GMT
Condition: Undifferentiated Pleomorphic Sarcoma
Intervention: Device: ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
Sponsors: Matthew Bucknor; Focused Ultrasound Foundation
Recruiting
-
Posted: August 28th, 2019, 2:00pm GMT
Condition: Sarcoma
Intervention:
Sponsors: The Netherlands Cancer Institute; Radboud University Medical Center; Leiden University Medical Center; Centre Leon Berard; University Hospital Carl Gustav Carus; Heidelberg University; Johannes Gutenberg University Mainz; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; National Cancer Institute, Naples; Maria Sklodowska-Curie National Research Institute of Oncology; Hospital San Carlos, Madrid; Royal Marsden NHS Foundation Trust; Beatson West of Scotland Cancer Centre; University Hospital Southampton NHS Foundation Trust; Royal National Orthopaedic Hospital NHS Trust; Bank of Cyprus Oncology Centre; Institut Català d'Oncologia; University of Adelaide; King Hussein Cancer Center; Oslo University Hospital; Erasmus Medical Center; University Medical Center Groningen; Centre Oscar Lambret; Aretaieio Hospital; Hospital Universitario Fundación Jiménez Díaz; The Christie NHS Foundation Trust; Ain Shams University; Prince of Wales Hospital, Shatin, Hong Kong; Sheba Medical Center
Recruiting
-
Posted: August 28th, 2019, 2:00pm GMT
Condition: Sarcoma
Intervention: Drug: Apatinib monotherapy
Sponsor: Ruijin Hospital
Recruiting
-
Posted: August 22nd, 2019, 2:00pm GMT
Condition: Kaposi Sarcoma
Intervention: Drug: Talimogene laherparepvec
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting
-
Posted: July 30th, 2019, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Gemcitabine; Drug: Docetaxel; Radiation: Radiation; Procedure: Surgical Resection; Other: Blood draws
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting
-
Posted: July 25th, 2019, 2:00pm GMT
Condition: Sarcoma
Intervention: Device: CivaSheet
Sponsors: CivaTech Oncology; TAB Clinical
Recruiting
-
Posted: July 19th, 2019, 2:00pm GMT
Condition: Sarcoma
Intervention: Drug: chidamide and toripalimab
Sponsor: Sun Yat-sen University
Recruiting
-
Posted: July 9th, 2019, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Drug: Apatinib Mesylate, doxorubicin, ifosfamide
Sponsors: Sun Yat-sen University; Jiangsu HengRui Medicine Co., Ltd.
Recruiting
-
Posted: June 20th, 2019, 2:00pm GMT
Condition: Kaposi Sarcoma
Intervention: Drug: sEphB4-HSA
Sponsor: Vasgene Therapeutics, Inc
Recruiting
-
Posted: June 6th, 2019, 2:00pm GMT
Condition: Sarcoma
Interventions: Drug: Chemotherapy; Drug: Immunotherapeutic Agent; Drug: target treatment; Procedure: Surgery; Radiation: Radiotherapy
Sponsors: Institut Bergonié; French Sarcoma Group
Recruiting
-
Posted: April 1st, 2019, 2:00pm GMT
Condition: Sarcoma
Interventions: Device: Preoperative RT; Device: Postoperative RT; Drug: Chemotherapy; Other: Surgery
Sponsor: Medical College of Wisconsin
Recruiting
-
Posted: March 26th, 2019, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Intervention: Drug: Anlotinib Hydrochloride
Sponsors: Sun Yat-sen University; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
-
Posted: March 22nd, 2019, 2:00pm GMT
Condition: Sarcoma
Interventions: Drug: Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC]; Drug: Nivolumab IV Soln 100 MG/10ML; Drug: Trabectedin 0.25 MG/1 VIAL Intravenous Powder for Solution
Sponsor: Sarcoma Oncology Research Center, LLC
Recruiting
-
Posted: February 12th, 2019, 3:00pm GMT
Condition: Advanced Soft Tissue Sarcoma
Interventions: Drug: Standard arm: Trabectedin in monotherapy; Drug: Experimental arm: Trabectedin + Olaparib
Sponsors: Italian Sarcoma Group; PharmaMar; AstraZeneca
Recruiting
-
Posted: February 12th, 2019, 3:00pm GMT
Condition: Retroperitoneal Sarcoma
Intervention:
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; TransAtlantic Retroperitoneal Sarcoma Working Group
Recruiting
-
Posted: January 11th, 2019, 3:00pm GMT
Condition: Sarcoma
Intervention: Biological: Blood samples
Sponsor: Centre Georges Francois Leclerc
Recruiting
-
Posted: January 9th, 2019, 3:00pm GMT
Condition: Sarcoma
Intervention: Drug: Durvalumab, pazopanib
Sponsor: Yonsei University
Recruiting
-
Posted: January 3rd, 2019, 3:00pm GMT
Condition: Retroperitoneal Sarcoma
Intervention: Drug: Doxorubicin
Sponsor: National Cancer Centre, Singapore
Recruiting
-
Posted: December 21st, 2018, 3:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Nilotinib; Drug: Ceritinib; Drug: Capmatinib; Drug: Lapatinib; Drug: Trametinib; Combination Product: Trametinib and Dabrafenib; Combination Product: Olaparib and Durvalumab; Drug: Palbociclib; Drug: Glasdegib; Drug: TAS-120; Other: Next Generation sequencing exome
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Commissariat A L'energie Atomique; Institut Bergonié; Plateforme labellisée Inca - Institut Bergonié, Bordeaux; Plateforme labellisée Inca - Hôpital Européen Georges Pompidou, Paris; EUCLID Clinical Trial Platform
Recruiting
-
Posted: December 19th, 2018, 3:00pm GMT
Conditions: Sarcoma, Ewing; Sarcoma
Intervention: Drug: Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)
Sponsors: Sarcoma Oncology Research Center, LLC; Joseph Ahmed Foundation; Tyme, Inc
Recruiting
-
Posted: October 25th, 2018, 2:00pm GMT
Condition: Soft Tissue Sarcoma
Interventions: Drug: Doxorubicin; Drug: APX005M
Sponsors: Columbia University; Apexigen, Inc.
Recruiting
-
Posted: March 12th, 2018, 2:00pm GMT
Conditions: Bone Sarcoma; Soft Tissue Sarcoma
Intervention: Biological: NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)
Sponsors: Sun Yat-sen University; Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Recruiting
-
Posted: February 1st, 2018, 3:00pm GMT
Condition: Sarcoma
Interventions: Drug: 18F-FAZA; Drug: Pimonidazole
Sponsor: University Health Network, Toronto
Recruiting
-
Posted: December 2nd, 2017, 3:00pm GMT
Condition: Ewing Sarcoma
Interventions: Drug: Vincristine; Drug: Temozolomide
Sponsor: Peking University People's Hospital
Recruiting
-
Posted: April 4th, 2017, 2:00pm GMT
Condition: Epithelioid Sarcoma
Intervention: Other: Treatment for Epitheloid Sarcoma
Sponsor: Italian Sarcoma Group
Recruiting
-
Posted: March 10th, 2017, 3:00pm GMT
Condition: Soft Tissue Sarcoma Adult
Intervention: Procedure: Geriatric assessment
Sponsors: Institut Bergonié; Ministry of Health, France
Recruiting
-
Posted: June 15th, 2016, 2:00pm GMT
Condition: Skin Kaposi Sarcoma
Interventions: Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Behavioral: Quality-of-Life Assessment; Biological: Recombinant EphB4-HSA Fusion Protein
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); Vasgene Therapeutics, Inc; The Emmes Company, LLC; University of Arkansas
Recruiting
-
Posted: June 3rd, 2016, 2:00pm GMT
Condition: Soft-tissue Sarcomas
Intervention: Other: Procedure/Surgery
Sponsors: Institut Bergonié; National Cancer Institute, France; Ministry of Health, France
Recruiting
-
Posted: June 1st, 2016, 2:00pm GMT
Condition: Soft-tissue Sarcoma
Interventions: Drug: Olaparib; Radiation: Concomitant Radiotherapy
Sponsors: Institut Bergonié; National Cancer Institute, France
Recruiting